"

Team:NTNU-Trondheim/Notebook/September

From 2013.igem.org

(Difference between revisions)

Revision as of 06:51, 4 October 2013

Trondheim iGEM 2013

Tuesday 03.09.2013

Analysis of sequencing results

Today we got back the sequencing results from last week (see Thursday 29.08.2013). The figures below show the alignments of the samples (always first line) and the expected sequences (always second line). Red indicates proper alignment, blue indicates mismatches.

Figure: Alignment of tat_ProteinG S2. As the last time there seems to be a deletion on a guanine residue that shifting the reading frame. In addition the last part of the sequence does not seem to match like S3 and D8 did.

Figure 1.

figures: Alignment of tat_ProteinG C4, tat_ProteinG C5, tat_ProteinG DT2, tat_ProteinG DT7 and tat_ProteinG DT10. None of these sequences makes any sense. It is safe to conclude that ProteinG is not in these sequences.

Figure 1.

figures: Alignment of tat_ProteinG DT5, tat_ProteinG DT6 and tat_ProteinG DT9. ProteinG seems to be there but most of tat is absent. Only the first part of tat is there.

Figure 1.

figures: Alignment of Gibson tCY 1, Gibson tCY 2, Gibson tCY 3 and SLIC tCY. tat and YFP is present, but CFP is absent in all of these sequences.

After the positive sequence results we had (see tuesday 27.08.2013), we decided to check weather there where any GFP in the ER1 and ER2 bacteria (see figure 8).
LB media samples with ER1, ER2 (see figure 8) and ''E.coli'' cells transformed with standard RFP, which served as a referance, were centrifuged. The palets were resuspended in DPBSS buffer. These solutions were den studied in a fluorometer by doing a excitation and emmision scan (see figures below):

Figure 1.

figures: Excitation and emission scan of ER1, ER2 and the referance sample with RFP.

There are no significant differance between the referance sample and the ER samples. It seems that GFP is not present or doesent fold properly.

Thursday 05.09.13

We wanted to try to fix the addition and deletion in tat-ProteinG DT and S3 (respectively) by using the forward primer for tat (F_pl.b_tat) that has the right sequence. PCR-reactions for amplifying the backbones (BB) and the tat_ProteinG of both DT8 and S3 were run. These 4 samples were then run on a gel to confirm the results (figure below).

Figure: PCR products of tat_ProteinG and BB from DT8 (well 1 and 2) and S3 (well 3 and 4). Ladder applied is [http://66.155.211.155/nebecomm/products_intl/productN3232.asp 1 kb DNA ladder]. The fragments nicely matches the expected sizes of 2800 bp for backbone and 1300-1400 for tat_proteinG.

The PCR products were also incubated at 37 °C with Dpn1 to remove all old plasmids. The PCR products where then used in direct transformation of ''E.coli'' DH5α. The fragments that originated from the same plasmid where used together (BB from DT8 with tat_PrG from DT8 and so on). There was also performed a direct transformation tat_GFPmut3 with BB from S3. There were made two parallels of all combinations yielding 6 direct transformation. Controls with all the 5 fragments used was also prepared.

Friday 06.09.13

PCR

Turned the Pm XylS promoter system into a biobrick using PCR. The following recipe was used: * 31.5 μl dH₂O * 10 μl 10x phusion buffer * 1 μl dNTPs * 2.5 μl fwd primer diluted 1:10 compared to stock solution (primer sequence: GAATTCGCGGCCGCTTCTAGTCAAGCCACTTCCTTTTTGC) * 2.5 μl rev primer diluted 1:10 compared to stock solution (primer sequence: TACTAGTAGCGGCCGCTGCAGTGCATAAAGCCTAAGGGGTAGG) * 1 μl template DNA * 1 μl DMSO * 0.5 μl Phusion DNA polymerase Two different templates were used, and two samples were made for each template, giving in total four PCR batches. The first template was the Pm XylS plasmid, while the second was a PCR product of the Pm XylS promoter, modified in order to eliminate an XbaI restriction site. The following PCR program was used: {|border="1" !Program step !Temperature !Duration |- |Heated lid |103°C | - |- |Initial denaturation |98°C |30 s |- |Cycle 30x | | |- |Denaturation |98°C |15 s |- |Annealing |64°C |15 s |- |Elongation |72°C |53 s |- |End of cycle | | |- |Final elongation |72°C |10 min |- |Hold |4°C |∞ |- |} Gel picture of the PCR products:

Figure 1.

[[file:Pm_XylS_BB.png|400px]] The PCR products were rinsed using the QIAgen PCR Purification kit. The two parallel samples using the same template were eluted in the same eppendorf tube. The following concentrations were measured: {|border="1" !BioBrick !Concentration |- |Pm XylS from BB template |98.3 ng/μl |- |Pm XylS with XbaI site |171.9 ng/μl |- |}

Miniprep

BBa_E0240 and pSB3K3 were isolated using the Wizard Plus SV Minipreps DNA Purification System kit. The following concentrations were measured after the isolation: {|border="1" !Part !Concentration |- |BBa_E0240 |79.8 ng/μl |- |pSB3K3 |42.8 ng/μl |- |}

Checking plates from Thursday 05.09.2013

All of the plates that should have colonies had colonies. The S3-1 plate had to be disregarded because the agar had detatched from the plastic plate. 4 of the 5 controls also had colonies, indicating that there where still colonies in the sample.

Sunday 08.09.2013

Two colonies from each of the usable plates (D8-1, D8-2, S3-1, tatGFPmut3-1 and tatGFPmut3-2) that where checked on friday 06.09 where transfered to LB media with ampenicillin.

Monday 09.09.2013

The bacterial culture from the day before where minipreped and the reminding plasmid samples where prepared for DNA-sequencing with the standard iGEM forward sequencing primer VF2. The samples where labled tatPrG D8-1A, tatPrG D8-1B, tatPrG D8-2A, tatPrG D8-2B, tatPrG S3-2A, tatPrG S3-2B, tatGFPmut3-1A, tatGFPmut3-1B, tatGFPmut3-2A and tatGFPmut3-2B. The samples where sent for DNA-sequencing the next day.

Tuesday 10.09.13

Restriction digest

Linearized pSB1C3 and the two versions of Pm XylS (modified and unmodified, one of them containing an XbaI restriction site) were cut with EcoRI and PstI in order to put the promoter system in the shipping plasmid. The following volumes of DNA and water were used in the digestions: {|border="1" !DNA part !Concentration of DNA !Calculated volume of DNA used in digestion !Volume of dH₂O used in digestion |- |Linearized pSB1C3 |25 ng/μl |10 μl |6 μl |- |Pm XylS BB |98.3 ng/μl |2.5 μl |13.5 μl |- |Pm XylS XbaI |171.9 ng/μl |1.5 μl |14.5 μl |- |} Buffer 3 were used in all restriction digests. In the table above, Pm XylS BB refers to the biobrick that has been modified compared to the original Pm XylS promoter, which contains an illegal XbaI restriction site. Pm XylS XbaI is the original promoter, that contains the XbaI site. After the restriction digest, the products were purified using the QIAquick PCR Purification Kit, which has a filter size that allows the short ends of the prefix and suffix of the linearized plasmids and biobricks that should be present after the restriction digest, to pass through the filter. The following concentrations were measured after the purification: {|border="1" !DNA part !Concentration |- |pSB1C3 |4.2 ng/μl |- |Pm XylS BB |6.8 ng/μl |- |Pm XylS XbaI |7.6 ng/μl |- |}

Gel electrophoresis

Gel electrophoresis were performed to ensure that the right DNA fragments are present after the restriction digest.

Figure 1.

[[file:PSB1C3+Pm_XylS_restriction_digest.png|400px]] In this picture, the first band is pSB1C3, which linearized should be 2070 bp long. The Pm XylS promoter system has a length of 1759 bp, and the modified and unmodified version of the promoter system corresponds to band 2 and 3.

Ligation

pSB1C3 was ligated to Pm XylS BB and Pm XylS XbaI, respectively. The following ligation mix was set up. The same mix were used for both promoter systems, since the concentrations were almost the same. The volume of backbone used corresponds to 25 ng of DNA, which is the recommended amount of backbone suggested on the partsregistry website. {|border="1" !Component !Volume |- |pSB1C3 |6 μl |- |Pm XylS BB / Pm XylS XbaI |7 μl |- |T4 DNA ligase buffer |1.5 μl |- |T4 DNA ligase |0.5 μl |- |} The ligation mix was put in the fridge for overnight ligation.

Wednesday 11.09.13

Transformation

The Pm XylS BB in pSB1C3 and PmXylS XbaI in pSB1C3 systems that were ligated overnight were transformed to competent ''E. coli'' DH5α cells and plated out on agar plates having chloramphenicol resistance. ====Thursday 12.09.13==== =====Transfer of cells from agar plates to liquid medium=====

Thursday 12.09.13

Transfer of cells from agar plates to liquid medium

The cells transformed yesterday were transferred to liquid medium containing 1 μg/ml chloramphenicol.

Another round of small-scale vesicle preparation

Step 1 and 2 of the small-scale vesicle preparation were performed with ER2566 transformed with the ER1 construct from the second Gibson assembly attempt that had a postive sequencing results. One colony were selected from the recently transformed bacteria plate and incubated for 16 hours in step 2 in a total of 1L LB. The cultures were incubated aerobically in LB media with ampenicillin (100 µL/mL) in step 1 and areobically in plain LB in step 2.

Friday 13.09.13

Miniprep

Pm XylS BB in pSB1C3 and Pm XylS XbaI in pSB1C3 was miniprepped using the Promega Wizard Plus SV Minipreps DNA Purification kit. The following concentrations were measured: {|border="1" !BioBrick !Concentration |- |Pm XylS BB + pSB1C3 |44.3 ng/μl |- |Pm XylS XbaI + pSB1C3 |67.0 ng/μl |- |}

Small-scale vesicle preparation

Step 4-12 of the small-scale vesicle preparation were performed with ER1. In addition a 10^-6 dilution of the sample were made and plating of 100µL of 1 mL of the dilution on Amp-LA was performed in step 4. The plates were left in the incubator overnight. The plate had growth, indicating that the bacteria still had their plasmid.
Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.436.
The cell cultures and cell pallets were not red or pink when they were taken out of the incubator and centrifuge. The pallet did, however, start to get a red color after a while.
Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and stored in the fridge.
RFU was measured as described in step 12 of the small-scale vesicle preparation<(/a> protcol. The blank sample had a value of 153 while the vesicle containing sample had the value of 2128.
There was also conducted a fluorecense scan of a undiluted sample without FM4-64. This will be desribed on "Sunday 15.09.2013".

Saturday 14.09.2013

Another round of small-scale vesicle preparation

A new round of vesicle isolation was started to create a referance to the ER1 from friday. Step 1 and 2 of the small-scale vesicle preparation were performed with unstransformed ER2566. In step 2 the bacteria was incubated for 16 hours in a total of one liter LB.

Transformation

All of the tat_ProteinG plasmids that where sent for sequencing (see monday 09.09.2013) where applied in a transformation of ''E.coli'' strain ER2566 by the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols#Transformation transformation protocol].

Sunday 15.09.2013

Small-scale vesicle preparation

Step 4-12 of the small-scale vesicle preparation were performed with unstransformed ER2566.
Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.351.
Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and was run with the SDS-PAGE from friday 13.09.2013. See figure below.

Figure 1.

[[file:vesicles WT_and_ER1.jpg|400px]] Figure: Ladder applied is Precision Plus Protein^TM Unstained Standards. WT stands for wildtype and is the unstransformed ER2566 samples.

There are noe additional bands in the ER1 samples compared to the unstransformed ER2566 sample, indicating that there are no GFP-RFP in the vesicles.
RFU was measured as decribed in step 12 of the small-scale vesicle preparation protocol. The blank sample had a value of 150 while the vesicle containing sample had the value of 8708.
There was run a excitation scan of the undiluted unstransformed ER2566 sample that was compared to the similar scan done on friday 13.09.2013. The results were as shown in the two figures below.

Figure 1.

[[file:fluor_ER1.jpg|400px]] [[file:fluor_WT.jpg|400px]] Figures: Fluorescence excitation scan of vesicles from the ER1 cells (left) and wildtype ER2566 (right). There are no real differance between the samples other then strength of the signals. Both samples have peaks at 504, 540 and 582 nm. It is likely that there are no tGR construct in the vesicles.

PCR and digestion for putting on a prefix on the tat-GFP-RFP construct

A PCR were run on the plasmid containing tat_GFP_RFP construct with the F_prefix_tat and R_pl.b primers. This would in theory give us a PCR product that is the same size as the original plasmid. 15 µL of the PCR-product and 4 µL of the linerized pSB1C3 backbone where digested with the Enzyme Master Mix for Plasmid Backbone according to the recomended protocole.
The PCR product and the digested PCR product were run on a agarose gel, giving the result as indicated in the figure below.

Figure 1.

[[file:PCR_digestion.jpg|550px]] Figure 10: Ladder applied is GeneRuler^TM 100 bp plus DNA ladder. The ladder is for some reason not completly functional.

As there were not just one band and the ladder was unreliable, no fragment was cut out of the gel.

Thursday 26.09.2013

PCR and digestion for creating a briobrick of tat_GFP_RF

PCR was run on the tat_GFP_RFP PCR-product from sunday 16.09. This time the F_prefix_tat primer and a reverse primer that anneals to the suffix in plasmid was applied. The PCR-prduct was digested with EcoRI and PstI. The digested PCR-product was run on a gel and one gelband was cut out. The fragment was purified with the QIAquick PCR Purification kit.

Ligation

The purified and digested (see above) tat_GFP_RFP with prefix was added into a ligation mix with the digested pSB1C3 backbone according to the iGEM protocole. The ligation product was transformed into DH5α cells.

Friday 27.09.2013

PCR on fluorescent proteins

PCR was run on YFP (BBa_E0030), CFP (BBa_E0020), GFP (BBa_E0040), BFP (BBa_K5921000) and SYFP (BBa_K864100) by using F_seq and R_seq as primers. These primers anneal to VF2 (BBa_G00100) and VR (BBa_G00101). The products were run on a gel and all samples had the expected size of about 1000 bp (see figure below).

[[file:FP_Anderson.jpg|550px]]

Figure 1.

Figure 10: Ladder applied is GeneRuler^TM 1 kb DNA ladder.

Saturday 21.09.2013

LOTS of stuff

Sunday 22.09.2013

Analysing DNA sequencing results

The results from the last round of sequencing (see monday 09.09) was analysed with the prefered sequence. The alignments were as follows:

Figure 1.

[[file:PrG D8-1A.jpg|230px]][[file:PrG D8-1B.jpg|230px]][[file:PrG D8-2A.jpg|230px]][[file:PrG D8-2B.jpg|230px]][[file:S3-2A.jpg|230px]] figures: Alignment of tat_ProteinG D8-1A, tat_ProteinG D8-1B, tat_ProteinG D8-2A, tat_ProteinG D-2B and tat_ProteinG S3-2A. These sequences either makes no sense or does not have the exact sequence we are looking for. These constructs will not be applied for later.

Figure 1.

[[file:PrG S3-2B.jpg|600px]] figure: Alignment of tat_ProteinG S3-2B. This sequence is just how its supposed to be and will be used later in a vesicle isolation. The alignments of the tat_GFPmut3 samples did not give any sense at all in will therefor not be included here as figures.

Monday 23.09.2013

Sending Biobricks

The biobricks tat_GFP_RFP (BBa_K1082001) and the Pm/XylS promoter system (BBa_K1082002) was sent in to the registery.

DNA samples sendt in for sequencing

The rest of the biobrick tat_GFP_RFP (BBa_K1082001) was sent in for sequencing with the F_seq and R_seq primers. The tat_ProteinG S3-2B (see sunday 22.09.2013) was also sent in for sequencing with the R_seq primer

Wednesday 25.09.2013

Step 1 and 2 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with ER2566 transformed with the tat_ProteinG S3-2B (see sequencing results for sunday 22.09.2013) that had a postive sequencing result. One colony were selected from the recently transformed bacteria plate and incubated for 16 hours in step 2 in a total of 1L LB. The cultures were incubated aerobically in LB media with ampenicillin (100 µL/mL) in step 1 and aerobically in plain LB in step 2.

Thursday 26.09.2013

Small-scale vesicle preparation

Step 4-12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with ER1. In addition a 10^-6 dilution of the sample were made and plating of 100µL of 1 mL of the dilution on Amp-LA was performed in step 4. The plates were left in the incubator overnight. The plate had growth, indicating that the bacteria still had their plasmid.
Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.165.
Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and stored in the fridge.
RFU was measured as decribed in step 12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] protcol. The blank sample had a value of 5531 while the vesicle containing sample had the value of 44 255.

Friday 27.09.2013

SDS-PAGE were performed with the samples from the day before (see figure below):

Figure 1.

[[file:vesicles_PrG.jpg|400px]] Figure: Ladder applied is Precision Plus Protein^TM Unstained Standards. The bands are not as visible as with the naked eye.

There are no additional bands compared with the wildtype ER2566 vesicles (see sunday 15.09) and therefore no indication that Protein G are in the vesicles.

Sunday 29.09.2013

Analysis of sequencing results

Results of DNA samples that were sent in for sequencing on monday 23.09 ware analysed.

Figure 1.

[[file:tGR_F.jpg|400px]] [[file:tGR_R.jpg|400px]] Figures: Sequencing results of the tat_GFP_RFP construct with the F_seq (left) and R_seq (right) primer.

The new sequencing results from the ER1 sample that is supposed to have the tat_GFP_RFP construct does not make sense. It is indeed very unclear why our construct suddenly is lost.

Figure 1.

[[file:PrG_RR.jpg|400px]] Figure: Sequencing results of the tat_ProteinG S3_2B construct with the R_seq primer.

Putting this tat_ProteinG results together with the results from sunday 22.09 with the forward (F_seq) primer gives the alignment as follows:

Figure 1.

[[file:PrG_R.jpg|400px]] Figure: Alignment of the full tat_ProteinG construct. The Protein G gene from the ''Streptococcus dysgalactiae ssp equisimilis'' sample we collected from the hospital are clearly missing two bigger segments compared to the [http://www.ncbi.nlm.nih.gov/nuccore/X06173 known gene sequence]. We conclude that this is Protein G as the rest of the sequence aligns well.

Retrieved from "http://2013.igem.org/Team:NTNU-Trondheim/Notebook/September"

@@ Line 60: / Line 60: @@
 </div>
-====<center>Tuesday 03.09.2013</center>====
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Tuesday 03.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
-=====Analysis of sequencing results=====
+<div class="row">
-Today we got back the sequencing results from last week (see Thursday 29.08.2013). The figures below show the alignments of the samples (always first line) and the expected sequences (always second line). Red indicates proper alignment, blue indicates mismatches.
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; ">Analysis of sequencing results</p> </div>
+<br><br>
+<p>Today we got back the sequencing results from last week (see Thursday 29.08.2013). The figures below show the alignments of the samples (always first line) and the expected sequences (always second line). Red indicates proper alignment, blue indicates mismatches.
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/6/6c/PrG_S2.jpg"> <img src="https://static.igem.org/mediawiki/2013/6/6c/PrG_S2.jpg" width="303">
@@ Line 151: / Line 160: @@
 <div class ="row-end"> </div>
 </div>
-----
 <div class="row">
@@ Line 159: / Line 166: @@
 <p style="text-align:center; color:black; ">Thursday 05.09.13</p> </div>
 <br><br>
-<p>We wanted to try to fix the addition and deletion in tat-ProteinG DT and S3 (respectively) by using the forward primer for tat (F_pl.b_tat) that has the right sequence. PCR-reactions for amplifying the backbones (BB) and the tat_ProteinG of both DT8 and S3 were run. These 4 samples were then run on a gel to confirm the results (figure below).
+<p>We wanted to try to fix the addition and deletion in tat-ProteinG DT and S3 (respectively) by using the forward primer for tat (F_pl.b_tat) that has the right sequence. PCR-reactions for amplifying the backbones (BB) and the tat_ProteinG of both DT8 and S3 were run. These 4 samples were then run on a gel to confirm the results (figure below).<br>
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/c/cf/PCR_on_DT8_and_S3.png"> <img src="https://static.igem.org/mediawiki/2013/c/cf/PCR_on_DT8_and_S3.png" width="303">
   <p style="text-align:center; color:black; "> Figure: PCR products of tat_ProteinG and BB from DT8 (well 1 and 2) and S3 (well 3 and 4). Ladder applied is [http://66.155.211.155/nebecomm/products_intl/productN3232.asp 1 kb DNA ladder]. The fragments nicely matches the expected sizes of 2800 bp for backbone and 1300-1400 for tat_proteinG.</p> </div>
@@ Line 171: / Line 178: @@
 </div>
-----
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Friday 06.09.13</p> </div>
+<div class ="row-end"> </div>
+</div
-====<center>Friday 06.09.13</center>====
+<div class="row">
+<div class="col12-3" align = "justify">
-=====PCR=====
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> PCR</p> </div>
-Turned the Pm XylS promoter system into a biobrick using PCR. The following recipe was used:
+<br><br>
+<p>Turned the Pm XylS promoter system into a biobrick using PCR. The following recipe was used:
 * 31.5 &mu;l dH<sub>2</sub>O
@@ Line 254: / Line 267: @@
 |-
 |}
-=====Miniprep=====
 <div class="row">
@@ Line 262: / Line 273: @@
 <p style="text-align:center; color:black; ">Miniprep</p> </div>
 <br><br>
-<p><partinfo>BBa_E0240</partinfo> and <partinfo>pSB3K3</partinfo> were isolated using the Wizard <i>Plus</i> SV Minipreps DNA Purification System kit. The following concentrations were measured after the isolation:
+<p><a href="http://parts.igem.org/BBa_E0240">BBa_E0240</a> and <a href="http://parts.igem.org/pSB3K3">pSB3K3</a> were isolated using the Wizard <i>Plus</i> SV Minipreps DNA Purification System kit. The following concentrations were measured after the isolation:
 {|border="1"
@@ Line 287: / Line 298: @@
 <div class ="row-end"> </div>
 </div>
-----
 <div class="row">
@@ Line 297: / Line 308: @@
 <div class ="row-end"> </div>
 </div>
-----
 <div class="row">
@@ Line 306: / Line 314: @@
 <p style="text-align:center; color:black; ">Monday 09.09.2013</p> </div>
 <br><br>
-<p>The bacterial culture from the day before where minipreped and the reminding plasmid samples where prepared for DNA-sequencing with the [http://parts.igem.org/Primers/Catalog standard iGEM forward sequencing primer VF2]. The samples where labled tatPrG D8-1A, tatPrG D8-1B, tatPrG D8-2A, tatPrG D8-2B, tatPrG S3-2A, tatPrG S3-2B, tatGFPmut3-1A, tatGFPmut3-1B, tatGFPmut3-2A and tatGFPmut3-2B. The samples where sent for DNA-sequencing the next day.<br></p>
+<p>The bacterial culture from the day before where minipreped and the reminding plasmid samples where prepared for DNA-sequencing with the <a href="http://parts.igem.org/Primers/Catalog"> standard iGEM forward sequencing primer VF2</>. The samples where labled tatPrG D8-1A, tatPrG D8-1B, tatPrG D8-2A, tatPrG D8-2B, tatPrG S3-2A, tatPrG S3-2B, tatGFPmut3-1A, tatGFPmut3-1B, tatGFPmut3-2A and tatGFPmut3-2B. The samples where sent for DNA-sequencing the next day.<br></p>
 <div class ="row-end"> </div>
 </div>
-----
-====<center>Tuesday 10.09.13</center>====
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; ">Tuesday 10.09.13</p> </div>
+<div class ="row-end"> </div>
+</div
-=====Restriction digest=====
+<div class="row">
+<div class="col12-3" align = "justify">
-Linearized pSB1C3 and the two versions of Pm XylS (modified and unmodified, one of them containing an XbaI restriction site) were cut with EcoRI and PstI in order to put the promoter system in the shipping plasmid. The following volumes of DNA and water were used in the digestions:
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; ">Restriction digest</p> </div>
+<br><br>
+<p>Linearized pSB1C3 and the two versions of Pm XylS (modified and unmodified, one of them containing an XbaI restriction site) were cut with EcoRI and PstI in order to put the promoter system in the shipping plasmid. The following volumes of DNA and water were used in the digestions:
 {|border="1"
@@ Line 411: / Line 426: @@
 </div>
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Wednesday 11.09.13</p> </div>
+<div class ="row-end"> </div>
+</div
-====Wednesday 11.09.13====
+<div class="row">
+<div class="col12-3" align = "justify">
-=====Transformation=====
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Transformation</p> </div>
-The Pm XylS BB in pSB1C3 and PmXylS XbaI in pSB1C3 systems that were ligated overnight were transformed to competent ''E. coli'' DH5&alpha; cells and plated out on agar plates having chloramphenicol resistance.
+<br><br>
+<p>The Pm XylS BB in pSB1C3 and PmXylS XbaI in pSB1C3 systems that were ligated overnight were transformed to competent ''E. coli'' DH5&alpha; cells and plated out on agar plates having chloramphenicol resistance.
 ====Thursday 12.09.13====
@@ Line 423: / Line 444: @@
 =====Transfer of cells from agar plates to liquid medium=====
-The cells transformed yesterday were transferred to liquid medium containing 1 &mu;g/ml chloramphenicol.
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Thursday 12.09.13</p> </div>
+<div class ="row-end"> </div>
+</div
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Transfer of cells from agar plates to liquid medium</p> </div>
+<br><br>
+<p>The cells transformed yesterday were transferred to liquid medium containing 1 &mu;g/ml chloramphenicol.<br></p><div class ="row-end"> </div>
+</div
 <div class="row">
@@ Line 430: / Line 464: @@
 <p style="text-align:center; color:black; ">Another round of small-scale vesicle preparation</p> </div>
 <br><br>
-<p>Step 1 and 2 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with ER2566 transformed with the ER1 construct from the second Gibson assembly attempt that had a postive sequencing results. One colony were selected from the recently transformed bacteria plate and incubated for 16 hours in step 2 in a total of 1L LB. The cultures were incubated aerobically in LB media with ampenicillin (100 &micro;L/mL) in step 1 and areobically in plain LB in step 2.<br></p>
+<p>Step 1 and 2 of the <a href="https://2013.igem.org/Team:NTNU-Trondheim/Protocols"> small-scale vesicle preparation</a> were performed with ER2566 transformed with the ER1 construct from the second Gibson assembly attempt that had a postive sequencing results. One colony were selected from the recently transformed bacteria plate and incubated for 16 hours in step 2 in a total of 1L LB. The cultures were incubated aerobically in LB media with ampenicillin (100 &micro;L/mL) in step 1 and areobically in plain LB in step 2.<br></p>
 <div class ="row-end"> </div>
 </div>
-====<central> Friday 13.09.13 </central>====
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Friday 13.09.13 </p> </div>
+<div class ="row-end"> </div>
+</div
-=====Miniprep=====
+<div class="row">
+<div class="col12-3" align = "justify">
-Pm XylS BB in pSB1C3 and Pm XylS XbaI in pSB1C3 was miniprepped using the Promega Wizard Plus SV Minipreps DNA Purification kit. The following concentrations were measured:
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Miniprep</p> </div>
+<br><br>
+<p>Pm XylS BB in pSB1C3 and Pm XylS XbaI in pSB1C3 was miniprepped using the Promega Wizard Plus SV Minipreps DNA Purification kit. The following concentrations were measured:
@@ Line 459: / Line 501: @@
 <p style="text-align:center; color:black; ">Small-scale vesicle preparation</p> </div>
 <br><br>
-<p>Step 4-12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with ER1. In addition a 10<sup>-6</sup> dilution of the sample were made and plating of 100&micro;L of 1 mL of the dilution on Amp-LA was performed in step 4. The plates were left in the incubator overnight. The plate had growth, indicating that the bacteria still had their plasmid.
+<p>Step 4-12 of the <a href="https://2013.igem.org/Team:NTNU-Trondheim/Protocols"> small-scale vesicle preparation</a> were performed with ER1. In addition a 10<sup>-6</sup> dilution of the sample were made and plating of 100&micro;L of 1 mL of the dilution on Amp-LA was performed in step 4. The plates were left in the incubator overnight. The plate had growth, indicating that the bacteria still had their plasmid.<br>
+Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.436.<br>
-Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.436
+The cell cultures and cell pallets were not red or pink when they were taken out of the incubator and centrifuge. The pallet did, however, start to get a red color after a while.<br>
+Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and stored in the fridge.<br>
-The cell cultures and cell pallets were not red or pink when they were taken out of the incubator and centrifuge. The pallet did, however, start to get a red color after a while.
+RFU was measured as described in step 12 of the <a href="https://2013.igem.org/Team:NTNU-Trondheim/Protocols"> small-scale vesicle preparation<(/a> protcol. The blank sample had a value of 153 while the vesicle containing sample had the value of 2128. <br>
-Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and stored in the fridge
-RFU was measured as decribed in step 12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] protcol. The blank sample had a value of 153 while the vesicle containing sample had the value of 2128
 There was also conducted a fluorecense scan of a undiluted sample without FM4-64. This will be desribed on "Sunday 15.09.2013".<br></p>
 <div class ="row-end"> </div>
 </div>
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; ">Saturday 14.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
-====<center>Saturday 14.09.2013</center>====
+<div class="row">
-=====Another round of small-scale vesicle preparation=====
+<div class="col12-3" align = "justify">
-A new round of vesicle isolation was started to create a referance to the ER1 from friday. Step 1 and 2 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with unstransformed ER2566. In step 2 the bacteria was incubated for 16 hours in a total of one liter LB.
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Another round of small-scale vesicle preparation</p> </div>
+<br><br>
+<p>A new round of vesicle isolation was started to create a referance to the ER1 from friday. Step 1 and 2 of the <a href="https://2013.igem.org/Team:NTNU-Trondheim/Protocols"> small-scale vesicle preparation</a> were performed with unstransformed ER2566. In step 2 the bacteria was incubated for 16 hours in a total of one liter LB.<br></p>
+<div class ="row-end"> </div>
+</div>
 <div class="row">
@@ Line 488: / Line 535: @@
 </div>
-====<center>Sunday 15.09.2013</center>====
+<div class="row">
-=====Small-scale vesicle preparation=====
+<div class="col12-3" align = "justify">
-Step 4-12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with unstransformed ER2566.
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; ">Sunday 15.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
-Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.351
+<div class="row">
+<div class="col12-3" align = "justify">
-Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and was run with the SDS-PAGE from friday 13.09.2013. See figure below
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Small-scale vesicle preparation</p> </div>
+<br><br>
+<p>Step 4-12 of the <a href="https://2013.igem.org/Team:NTNU-Trondheim/Protocols"> small-scale vesicle preparation</a> were performed with unstransformed ER2566.<br>
+Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.351.<br>
+Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and was run with the SDS-PAGE from friday 13.09.2013. See figure below.<br>
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg"> <img src="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg" width="303">
@@ Line 505: / Line 560: @@
-There are noe additional bands in the ER1 samples compared to the unstransformed ER2566 sample, indicating that there are no GFP-RFP in the vesicles.
+<div class="row">
+<div class="col12-3" align = "justify">
-RFU was measured as decribed in step 12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] protcol. The blank sample had a value of 150 while the vesicle containing sample had the value of 8708
+<p>There are noe additional bands in the ER1 samples compared to the unstransformed ER2566 sample, indicating that there are no GFP-RFP in the vesicles.<br>
+RFU was measured as decribed in step 12 of the <a href="https://2013.igem.org/Team:NTNU-Trondheim/Protocols"> small-scale vesicle preparation</a> protocol. The blank sample had a value of 150 while the vesicle containing sample had the value of 8708.<br>
-There was run a excitation scan of the undiluted unstransformed ER2566 sample that was compared to the similar scan done on friday 13.09.2013. The results were as shown in the two figures below.
+There was run a excitation scan of the undiluted unstransformed ER2566 sample that was compared to the similar scan done on friday 13.09.2013. The results were as shown in the two figures below.<br></p>
+<div class ="row-end"> </div>
+</div>
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg"> <img src="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg" width="303">
@@ Line 527: / Line 584: @@
 <p style="text-align:center; color:black; ">PCR and digestion for putting on a prefix on the tat-GFP-RFP construct</p> </div>
 <br><br>
-<p>A PCR were run on the plasmid containing tat_GFP_RFP construct with the F_prefix_tat and R_pl.b primers. This would in theory give us a PCR product that is the same size as the original plasmid. 15 &micro;L of the PCR-product and 4 &micro;L of the linerized pSB1C3 backbone where digested with the [http://parts.igem.org/Help:Protocols/Linearized_Plasmid_Backbones Enzyme Master Mix for Plasmid Backbone] according to the [http://parts.igem.org/Help:Protocols/Linearized_Plasmid_Backbones recomended protocole].
+<p>A PCR were run on the plasmid containing tat_GFP_RFP construct with the F_prefix_tat and R_pl.b primers. This would in theory give us a PCR product that is the same size as the original plasmid. 15 &micro;L of the PCR-product and 4 &micro;L of the linerized pSB1C3 backbone where digested with the <a href="http://parts.igem.org/Help:Protocols/Linearized_Plasmid_Backbones"> Enzyme Master Mix for Plasmid Backbone</a> according to the <a href="http://parts.igem.org/Help:Protocols/Linearized_Plasmid_Backbones"> recomended protocole</a>.<br>
+The PCR product and the digested PCR product were run on a agarose gel, giving the result as indicated in the figure below.<br>
-The PCR product and the digested PCR product were run on a agarose gel, giving the result as indicated in the figure below.
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg"> <img src="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg" width="303">
   <p style="text-align:center; color:black; "> Figure 1.</p> </div>
@@ Line 538: / Line 595: @@
 <center>Figure 10: Ladder applied is GeneRuler<sup>TM</sup> 100 bp plus DNA ladder. The ladder is for some reason not completly functional.</center>
+<div class="row">
+<div class="col12-2" align = "justify">
 As there were not just one band and the ladder was unreliable, no fragment was cut out of the gel.<br></p>
 <div class ="row-end"> </div>
 </div>
-----
-====<center>Thursday 26.09.2013</center>====
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Thursday 26.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
-=====PCR and digestion for creating a briobrick of tat_GFP_RFP=====
+<div class="row">
-PCR was run on the tat_GFP_RFP PCR-product from sunday 16.09. This time the F_prefix_tat primer and a reverse primer that anneals to the suffix in plasmid was applied. The PCR-prduct was digested with EcoRI and PstI. The digested PCR-product was run on a gel and one gelband was cut out. The fragment was purified with the [http://www.qiagen.com/Products/Catalog/Sample-Technologies/DNA-Sample-Technologies/DNA-Cleanup/QIAquick-PCR-Purification-Kit#productdetails QIAquick PCR Purification kit]
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> PCR and digestion for creating a briobrick of tat_GFP_RF</p> </div>
+<br><br>
+<p>PCR was run on the tat_GFP_RFP PCR-product from sunday 16.09. This time the F_prefix_tat primer and a reverse primer that anneals to the suffix in plasmid was applied. The PCR-prduct was digested with EcoRI and PstI. The digested PCR-product was run on a gel and one gelband was cut out. The fragment was purified with the <a href="http://www.qiagen.com/Products/Catalog/Sample-Technologies/DNA-Sample-Technologies/DNA-Cleanup/QIAquick-PCR-Purification-Kit#productdetails"> QIAquick PCR Purification kit</a>.<br></p>
+<div class ="row-end"> </div>
+</div
 <div class="row">
@@ Line 554: / Line 623: @@
 <p style="text-align:center; color:black; ">Ligation</p> </div>
 <br><br>
-<p>The purified and digested (see above) tat_GFP_RFP with prefix was added into a ligation mix with the digested pSB1C3 backbone according to the [http://parts.igem.org/Help:Protocols/Linearized_Plasmid_Backbones iGEM protocole]. The ligation product was transformed into DH5&alpha; cells.
+<p>The purified and digested (see above) tat_GFP_RFP with prefix was added into a ligation mix with the digested pSB1C3 backbone according to the <a href="http://parts.igem.org/Help:Protocols/Linearized_Plasmid_Backbones"> iGEM protocole</a>. The ligation product was transformed into DH5&alpha; cells.<br></p>
+<div class ="row-end"> </div>
+</div
-====<center>Friday 27.09.2013</center>====
+<div class="row">
-=====PCR on fluorescent proteins=====
+<div class="col12-3" align = "justify">
-PCR was run on YFP (<partinfo>BBa_E0030</partinfo>), CFP (<partinfo>BBa_E0020</partinfo>), GFP (<partinfo>BBa_E0040</partinfo>), BFP (<partinfo>BBa_K592100</partinfo>) and SYFP (<partinfo>BBa_K864100</partinfo>) by using F_seq and R_seq as primers. These primers anneal to VF2 (<partinfo>BBa_G00100</partinfo>) and VR (<partinfo>BBa_G00101</partinfo>). The products were run on a gel and all samples had the expected size of about 1000 bp (see figure below).
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Friday 27.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> PCR on fluorescent proteins</p> </div>
+<br><br>
+<p>PCR was run on YFP (<a href="http://parts.igem.org/BBa_E0030">BBa_E0030</a>), CFP (<a href="http://parts.igem.org/BBa_E0020">BBa_E0020</a>), GFP (<a href="http://parts.igem.org/BBa_E0040">BBa_E0040</a>), BFP (<a href="http://parts.igem.org/BBa_K592100">BBa_K5921000</a>) and SYFP (<a href="http://parts.igem.org/BBa_K864100">BBa_K864100</a>) by using F_seq and R_seq as primers. These primers anneal to VF2 (<a href="http://parts.igem.org/BBa_G00100">BBa_G00100</a>) and VR (<a href="http://parts.igem.org/BBa_G00101">BBa_G00101</a>). The products were run on a gel and all samples had the expected size of about 1000 bp (see figure below).<br>
 <center>[[file:FP_Anderson.jpg|550px]]</center>
@@ Line 569: / Line 650: @@
-----
-====<center>Saturday 21.09.2013</center>====
 <div class="row">
 <div class="col12-2" align = "justify">
@@ Line 581: / Line 660: @@
-----
+<div class="row">
-====<center>Sunday 22.09.2013</center>====
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Sunday 22.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Analysing DNA sequencing results</p> </div>
+<br><br>
+<p>The results from the last round of sequencing (see monday 09.09) was analysed with the prefered sequence. The alignments were as follows:<br>
-=====Analysing DNA sequencing results=====
-The results from the last round of sequencing (see monday 09.09) was analysed with the prefered sequence. The alignments were as follows:
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg"> <img src="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg" width="303">
   <p style="text-align:center; color:black; "> Figure 1.</p> </div>
@@ Line 618: / Line 706: @@
 <center>figure: Alignment of tat_ProteinG S3-2B. This sequence is just how its supposed to be and will be used later in a vesicle isolation.</center>
-The alignments of the tat_GFPmut3 samples did not give any sense at all in will therefor not be included here as figures.
+The alignments of the tat_GFPmut3 samples did not give any sense at all in will therefor not be included here as figures.<br></p>
+<div class ="row-end"> </div>
+</div
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; ">Monday 23.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
-----
+<div class="row">
-====<center>Monday 23.09.2013</center>====
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
-=====Sending Biobricks=====
+<p style="text-align:center; color:black; "> Sending Biobricks</p> </div>
-The biobricks tat_GFP_RFP (BBa_K1082001) and the Pm/XylS promoter system (BBa_K1082002) was sent in to the registery.
+<br><br>
+<p>The biobricks tat_GFP_RFP (BBa_K1082001) and the Pm/XylS promoter system (BBa_K1082002) was sent in to the registery.<br>
@@ Line 637: / Line 734: @@
 <div class ="row-end"> </div>
 </div>
-----
 <div class="row">
@@ Line 648: / Line 743: @@
 <div class ="row-end"> </div>
 </div>
-----
-====<center>Thursday 26.09.2013</center>====
-=====Small-scale vesicle preparation=====
-Step 4-12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with ER1. In addition a 10<sup>-6</sup> dilution of the sample were made and plating of 100&micro;L of 1 mL of the dilution on Amp-LA was performed in step 4. The plates were left in the incubator overnight. The plate had growth, indicating that the bacteria still had their plasmid.
-Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.165
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Thursday 26.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
-Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and stored in the fridge
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Small-scale vesicle preparation</p> </div>
+<br><br>
+<p>Step 4-12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] were performed with ER1. In addition a 10<sup>-6</sup> dilution of the sample were made and plating of 100&micro;L of 1 mL of the dilution on Amp-LA was performed in step 4. The plates were left in the incubator overnight. The plate had growth, indicating that the bacteria still had their plasmid.<br>
+Optical denisty (OD) at 600 nm was mesured in step 4. The samples were diluted 1:10 with LB media and had a value of 0.165.<br>
+Samples for SDS-PAGE (one undiluted and one diluted 1:2) was prepared in step 12 and stored in the fridge.<br>
+RFU was measured as decribed in step 12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] protcol. The blank sample had a value of 5531 while the vesicle containing sample had the value of 44 255.<br></p>
+<div class ="row-end"> </div>
+</div
-RFU was measured as decribed in step 12 of the [https://2013.igem.org/Team:NTNU-Trondheim/Protocols small-scale vesicle preparation] protcol. The blank sample had a value of 5531 while the vesicle containing sample had the value of 44 255.
-----
 <div class="row">
@@ Line 675: / Line 778: @@
 <center>Figure: Ladder applied is Precision Plus Protein<sup>TM</sup> Unstained Standards. The bands are not as visible as with the naked eye.</center>
+<div class="row">
-There are no additional bands compared with the wildtype ER2566 vesicles (see sunday 15.09) and therefore no indication that Protein G are in the vesicles.<br></p>
+<div class="col12-2" align = "justify">
+<p>There are no additional bands compared with the wildtype ER2566 vesicles (see sunday 15.09) and therefore no indication that Protein G are in the vesicles.<br></p>
 <div class ="row-end"> </div>
 </div>
-----
-====<center>Sunday 29.09.2013</center>====
+<div class="row">
-=====Analysis of sequencing results=====
+<div class="col12-3" align = "justify">
-Results of DNA samples that were sent in for sequencing on monday 23.09 ware analysed.
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Sunday 29.09.2013</p> </div>
+<div class ="row-end"> </div>
+</div
+<div class="row">
+<div class="col12-3" align = "justify">
+<div class="col12-3" align = "center" style="background-color:white;>
+<p style="text-align:center; color:black; "> Analysis of sequencing results</p> </div>
+<br><br>
+<p>Results of DNA samples that were sent in for sequencing on monday 23.09 ware analysed.
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg"> <img src="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg" width="303">
   <p style="text-align:center; color:black; "> Figure 1.</p> </div>
@@ Line 696: / Line 809: @@
 <center>Figures: Sequencing results of the tat_GFP_RFP construct with the F_seq (left) and R_seq (right) primer. </center>
+<div class="row">
-The new sequencing results from the ER1 sample that is supposed to have the tat_GFP_RFP construct does not make sense. It is indeed very unclear why our construct suddenly is lost.
+<div class="col12-3" align = "justify">
+<p>The new sequencing results from the ER1 sample that is supposed to have the tat_GFP_RFP construct does not make sense. It is indeed very unclear why our construct suddenly is lost.
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg"> <img src="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg" width="303">
@@ Line 707: / Line 821: @@
 <center>Figure: Sequencing results of the tat_ProteinG S3_2B construct with the R_seq primer. </center>
+<div class="row">
-Putting this tat_ProteinG results together with the results from sunday 22.09 with the forward (F_seq) primer gives the alignment as follows:
+<div class="col12-3" align = "justify">
+<p>Putting this tat_ProteinG results together with the results from sunday 22.09 with the forward (F_seq) primer gives the alignment as follows:<br>
 <div class="col4" style="background-color:white;><a href="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg"> <img src="https://static.igem.org/mediawiki/2013/f/f9/Vesicles_trial_1.jpg" width="303">